标题
How I treat Gaucher disease
作者
关键词
-
出版物
BLOOD
Volume 118, Issue 6, Pages 1463-1471
出版商
American Society of Hematology
发表日期
2011-06-14
DOI
10.1182/blood-2011-04-308890
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement
- (2011) Eman M Sherif et al. BLOOD COAGULATION & FIBRINOLYSIS
- The management of pregnancy in Gaucher disease
- (2011) Sorina Granovsky-Grisaru et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Hyperferritinemia and iron overload in type 1 Gaucher disease
- (2010) Philip Stein et al. AMERICAN JOURNAL OF HEMATOLOGY
- Recombinant Glucocerebrosidase (Imiglucerase) as a Therapy for Gaucher Disease
- (2010) Gregory M. Pastores BIODRUGS
- Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
- (2010) A. Zimran et al. BLOOD
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply
- (2010) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Short-term withdrawal from imiglucerase: What can we learn from it?
- (2010) Carla E.M. Hollak BLOOD CELLS MOLECULES AND DISEASES
- Preimplantation genetic diagnosis (PGD) for a treatable disorder: Gaucher disease type 1 as a model
- (2010) Gheona Altarescu et al. BLOOD CELLS MOLECULES AND DISEASES
- Hip arthroplasty in patients with Gaucher disease
- (2010) Ehud Lebel et al. BLOOD CELLS MOLECULES AND DISEASES
- Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage
- (2010) Pilar Giraldo et al. BLOOD CELLS MOLECULES AND DISEASES
- Enzyme replacement therapy “drug holiday”: Results from an unexpected shortage of an orphan drug supply in Australia
- (2010) Jack Goldblatt et al. BLOOD CELLS MOLECULES AND DISEASES
- Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease
- (2010) Deborah Elstein et al. CLINICAL GENETICS
- The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
- (2010) Arash Velayati et al. Current Neurology and Neuroscience Reports
- High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease
- (2010) Tamar H. Taddei et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy
- (2010) Philip Stein et al. JOURNAL OF INHERITED METABOLIC DISEASE
- False-positive results using a Gaucher diagnostic kit – RecTL and N370S
- (2010) Jae Hyuk Choi et al. MOLECULAR GENETICS AND METABOLISM
- Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: What have we learned?
- (2010) Yael Eitan et al. PRENATAL DIAGNOSIS
- The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
- (2009) Tamar H. Taddei et al. AMERICAN JOURNAL OF HEMATOLOGY
- The female Gaucher patient: The impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)
- (2009) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Recommendations for treating patients with Gaucher disease with emerging enzyme products
- (2009) Timothy M. Cox BLOOD CELLS MOLECULES AND DISEASES
- Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
- (2009) Carla E.M. Hollak et al. BLOOD CELLS MOLECULES AND DISEASES
- Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
- (2009) Pramod K. Mistry et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study
- (2009) KB Sims et al. CLINICAL GENETICS
- Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1
- (2009) Gregory A Grabowski et al. GENETICS IN MEDICINE
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Management of neuronopathic Gaucher disease: Revised recommendations
- (2009) A. Vellodi et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme
- (2009) Carla E. M. Hollak et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation
- (2009) David Aviezer et al. PLoS One
- A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase
- (2008) Neal Weinreb et al. AMERICAN JOURNAL OF HEMATOLOGY
- Life expectancy in Gaucher disease type 1
- (2008) Neal J. Weinreb et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
- (2008) M. de Fost et al. ANNALS OF HEMATOLOGY
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Isofagomine Induced Stabilization of Glucocerebrosidase
- (2008) Gregory J. Kornhaber et al. CHEMBIOCHEM
- Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy
- (2008) M. de Fost et al. HAEMATOLOGICA
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
- (2008) Kathleen S. Hruska et al. HUMAN MUTATION
- ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature
- (2008) M. Biegstraaten et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Successful Low-Risk Hematopoietic Cell Therapy in a Mouse Model of Type 1 Gaucher Disease
- (2008) Ida Berglin Enquist et al. STEM CELLS
- Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy
- (2007) M. Langeveld et al. BLOOD CELLS MOLECULES AND DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now